Xencor (XNCR) Total Debt (2023 - 2026)
Xencor's (XNCR) quarterly Total Debt came in at $108.5 million in Q1 2026, down 29.7% year-on-year from $154.4 million in Q1 2025, and down 9.37% on a QoQ basis from $119.7 million in Q4 2025.
Xencor (XNCR) Total Debt (2023 - 2026) Analysis & Trends
Xencor (XNCR) has 4 years of Total Debt data on file, last reported at $108.5 million in Q1 2026.
- On a quarterly basis, Total Debt fell 29.7% year-over-year to $108.5 million in Q1 2026; TTM through Mar 2026 was $108.5 million, a 29.7% decrease from a year earlier, with the FY2025 full-year figure at $119.7 million, down 26.81% from the prior year.
- Total Debt for Q1 2026 stood at $108.5 million, down from $119.7 million in the prior quarter.
- Over the last five years, Total Debt for XNCR reached as high as $189.5 million in Q4 2023 and fell as low as $108.5 million in Q1 2026.
- Historically, Total Debt has averaged $155.2 million across 4 years, with a median of $159.0 million in 2024.
- Across the five-year window, Total Debt dropped 13.66% in 2024 and declined 29.7% in 2026, its largest moves.
- Year by year, Total Debt stood at $189.5 million in 2023, then decreased by 13.66% to $163.6 million in 2024, then slipped by 26.81% to $119.7 million in 2025, then decreased by 9.37% to $108.5 million in 2026.
- Per Business Quant data, the three most recent Total Debt figures were $108.5 million in Q1 2026, $119.7 million in Q4 2025, and $133.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 110.96 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 959.06 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.99 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Xencor | 1.47 Bn | 1.09 Bn | - | 108.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 108.53 Mn |
| Dec 31, 2025 | 119.75 Mn |
| Sep 30, 2025 | 133.14 Mn |
| Jun 30, 2025 | 145.02 Mn |
| Mar 31, 2025 | 154.38 Mn |
| Dec 31, 2024 | 163.61 Mn |
| Sep 30, 2024 | 172.80 Mn |
| Jun 30, 2024 | 179.76 Mn |
| Mar 31, 2024 | 185.10 Mn |
| Dec 31, 2023 | 189.48 Mn |